13,947 research outputs found
Recommended from our members
Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma
Conventional differential expression analyses have been successfully employed to identify genes whose levels change across experimental conditions. One limitation of this approach is the inability to discover central regulators that control gene expression networks. In addition, while methods for identifying central nodes in a network are widely implemented, the bioinformatics validation process and the theoretical error estimates that reflect the uncertainty in each step of the analysis are rarely considered. Using the betweenness centrality measure, we identified Etv5 as a potential tissue-level regulator in murine neurofibromatosis type 1 (Nf1) low-grade brain tumors (optic gliomas). As such, the expression of Etv5 and Etv5 target genes were increased in multiple independently-generated mouse optic glioma models relative to non-neoplastic (normal healthy) optic nerves, as well as in the cognate human tumors (pilocytic astrocytoma) relative to normal human brain. Importantly, differential Etv5 and Etv5 network expression was not directly the result of Nf1 gene dysfunction in specific cell types, but rather reflects a property of the tumor as an aggregate tissue. Moreover, this differential Etv5 expression was independently validated at the RNA and protein levels. Taken together, the combined use of network analysis, differential RNA expression findings, and experimental validation highlights the potential of the computational network approach to provide new insights into tumor biology
A hidden spatial-temporal Markov random field model for network-based analysis of time course gene expression data
Microarray time course (MTC) gene expression data are commonly collected to
study the dynamic nature of biological processes. One important problem is to
identify genes that show different expression profiles over time and pathways
that are perturbed during a given biological process. While methods are
available to identify the genes with differential expression levels over time,
there is a lack of methods that can incorporate the pathway information in
identifying the pathways being modified/activated during a biological process.
In this paper we develop a hidden spatial-temporal Markov random field
(hstMRF)-based method for identifying genes and subnetworks that are related to
biological processes, where the dependency of the differential expression
patterns of genes on the networks are modeled over time and over the network of
pathways. Simulation studies indicated that the method is quite effective in
identifying genes and modified subnetworks and has higher sensitivity than the
commonly used procedures that do not use the pathway structure or time
dependency information, with similar false discovery rates. Application to a
microarray gene expression study of systemic inflammation in humans identified
a core set of genes on the KEGG pathways that show clear differential
expression patterns over time. In addition, the method confirmed that the
TOLL-like signaling pathway plays an important role in immune response to
endotoxins.Comment: Published in at http://dx.doi.org/10.1214/07--AOAS145 the Annals of
Applied Statistics (http://www.imstat.org/aoas/) by the Institute of
Mathematical Statistics (http://www.imstat.org
Defining a robust biological prior from Pathway Analysis to drive Network Inference
Inferring genetic networks from gene expression data is one of the most
challenging work in the post-genomic era, partly due to the vast space of
possible networks and the relatively small amount of data available. In this
field, Gaussian Graphical Model (GGM) provides a convenient framework for the
discovery of biological networks. In this paper, we propose an original
approach for inferring gene regulation networks using a robust biological prior
on their structure in order to limit the set of candidate networks.
Pathways, that represent biological knowledge on the regulatory networks,
will be used as an informative prior knowledge to drive Network Inference. This
approach is based on the selection of a relevant set of genes, called the
"molecular signature", associated with a condition of interest (for instance,
the genes involved in disease development). In this context, differential
expression analysis is a well established strategy. However outcome signatures
are often not consistent and show little overlap between studies. Thus, we will
dedicate the first part of our work to the improvement of the standard process
of biomarker identification to guarantee the robustness and reproducibility of
the molecular signature.
Our approach enables to compare the networks inferred between two conditions
of interest (for instance case and control networks) and help along the
biological interpretation of results. Thus it allows to identify differential
regulations that occur in these conditions. We illustrate the proposed approach
by applying our method to a study of breast cancer's response to treatment
Identification of transcriptional regulatory networks specific to pilocytic astrocytoma.
BackgroundPilocytic Astrocytomas (PAs) are common low-grade central nervous system malignancies for which few recurrent and specific genetic alterations have been identified. In an effort to better understand the molecular biology underlying the pathogenesis of these pediatric brain tumors, we performed higher-order transcriptional network analysis of a large gene expression dataset to identify gene regulatory pathways that are specific to this tumor type, relative to other, more aggressive glial or histologically distinct brain tumours.MethodsRNA derived from frozen human PA tumours was subjected to microarray-based gene expression profiling, using Affymetrix U133Plus2 GeneChip microarrays. This data set was compared to similar data sets previously generated from non-malignant human brain tissue and other brain tumour types, after appropriate normalization.ResultsIn this study, we examined gene expression in 66 PA tumors compared to 15 non-malignant cortical brain tissues, and identified 792 genes that demonstrated consistent differential expression between independent sets of PA and non-malignant specimens. From this entire 792 gene set, we used the previously described PAP tool to assemble a core transcriptional regulatory network composed of 6 transcription factor genes (TFs) and 24 target genes, for a total of 55 interactions. A similar analysis of oligodendroglioma and glioblastoma multiforme (GBM) gene expression data sets identified distinct, but overlapping, networks. Most importantly, comparison of each of the brain tumor type-specific networks revealed a network unique to PA that included repressed expression of ONECUT2, a gene frequently methylated in other tumor types, and 13 other uniquely predicted TF-gene interactions.ConclusionsThese results suggest specific transcriptional pathways that may operate to create the unique molecular phenotype of PA and thus opportunities for corresponding targeted therapeutic intervention. Moreover, this study also demonstrates how integration of gene expression data with TF-gene and TF-TF interaction data is a powerful approach to generating testable hypotheses to better understand cell-type specific genetic programs relevant to cancer
Positively Correlated miRNA-miRNA Regulatory Networks in Mouse Frontal Cortex During Early Stages of Alcohol Dependence
Although the study of gene regulation via the action of specific microRNAs (miRNAs) has experienced a boom in recent years, the analysis of genome-wide interaction networks among miRNAs and respective targeted mRNAs has lagged behind. MicroRNAs simultaneously target many transcripts and fine-tune the expression of genes through cooperative/combinatorial targeting. Therefore, they have a large regulatory potential that could widely impact development and progression of diseases, as well as contribute unpredicted collateral effects due to their natural, pathophysiological, or treatment-induced modulation. We support the viewpoint that whole mirnome-transcriptome interaction analysis is required to better understand the mechanisms and potential consequences of miRNA regulation and/or deregulation in relevant biological models. In this study, we tested the hypotheses that ethanol consumption induces changes in miRNA-mRNA interaction networks in the mouse frontal cortex and that some of the changes observed in the mouse are equivalent to changes in similar brain regions from human alcoholics. Results: miRNA-mRNA interaction networks responding to ethanol insult were identified by differential expression analysis and weighted gene coexpression network analysis (WGCNA). Important pathways (coexpressed modular networks detected by WGCNA) and hub genes central to the neuronal response to ethanol are highlighted, as well as key miRNAs that regulate these processes and therefore represent potential therapeutic targets for treating alcohol addiction. Importantly, we discovered a conserved signature of changing miRNAs between ethanol-treated mice and human alcoholics, which provides a valuable tool for future biomarker/diagnostic studies in humans. We report positively correlated miRNA-mRNA expression networks that suggest an adaptive, targeted miRNA response due to binge ethanol drinking. Conclusions: This study provides new evidence for the role of miRNA regulation in brain homeostasis and sheds new light on current understanding of the development of alcohol dependence. To our knowledge this is the first report that activated expression of miRNAs correlates with activated expression of mRNAs rather than with mRNA downregulation in an in vivo model. We speculate that early activation of miRNAs designed to limit the effects of alcohol-induced genes may be an essential adaptive response during disease progression.NIAAA 5R01AA012404, 5P20AA017838, 5U01AA013520, P01AA020683, 5T32AA007471-24/25Waggoner Center for Alcohol and Addiction Researc
From data towards knowledge: Revealing the architecture of signaling systems by unifying knowledge mining and data mining of systematic perturbation data
Genetic and pharmacological perturbation experiments, such as deleting a gene
and monitoring gene expression responses, are powerful tools for studying
cellular signal transduction pathways. However, it remains a challenge to
automatically derive knowledge of a cellular signaling system at a conceptual
level from systematic perturbation-response data. In this study, we explored a
framework that unifies knowledge mining and data mining approaches towards the
goal. The framework consists of the following automated processes: 1) applying
an ontology-driven knowledge mining approach to identify functional modules
among the genes responding to a perturbation in order to reveal potential
signals affected by the perturbation; 2) applying a graph-based data mining
approach to search for perturbations that affect a common signal with respect
to a functional module, and 3) revealing the architecture of a signaling system
organize signaling units into a hierarchy based on their relationships.
Applying this framework to a compendium of yeast perturbation-response data, we
have successfully recovered many well-known signal transduction pathways; in
addition, our analysis have led to many hypotheses regarding the yeast signal
transduction system; finally, our analysis automatically organized perturbed
genes as a graph reflecting the architect of the yeast signaling system.
Importantly, this framework transformed molecular findings from a gene level to
a conceptual level, which readily can be translated into computable knowledge
in the form of rules regarding the yeast signaling system, such as "if genes
involved in MAPK signaling are perturbed, genes involved in pheromone responses
will be differentially expressed"
Post-transcriptional knowledge in pathway analysis increases the accuracy of phenotypes classification
Motivation: Prediction of phenotypes from high-dimensional data is a crucial
task in precision biology and medicine. Many technologies employ genomic
biomarkers to characterize phenotypes. However, such elements are not
sufficient to explain the underlying biology. To improve this, pathway analysis
techniques have been proposed. Nevertheless, such methods have shown lack of
accuracy in phenotypes classification. Results: Here we propose a novel
methodology called MITHrIL (Mirna enrIched paTHway Impact anaLysis) for the
analysis of signaling pathways, which has built on top of the work of Tarca et
al., 2009. MITHrIL extends pathways by adding missing regulatory elements, such
as microRNAs, and their interactions with genes. The method takes as input the
expression values of genes and/or microRNAs and returns a list of pathways
sorted according to their deregulation degree, together with the corresponding
statistical significance (p-values). Our analysis shows that MITHrIL
outperforms its competitors even in the worst case. In addition, our method is
able to correctly classify sets of tumor samples drawn from TCGA. Availability:
MITHrIL is freely available at the following URL:
http://alpha.dmi.unict.it/mithril
- …